고새머바이오(주)
DE ˙ DB ˙ US38341P1021
€0.17 ↓ -0.02 (-12.60%)
2026-06-02
주가
SecurityDE:4GB / Gossamer Bio, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership1,319,485 shares
Ownership 1.39%
State Street Corp ownership in 4GB / Gossamer Bio, Inc.

2023-05-10 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,319,485 shares of Gossamer Bio, Inc. (DE:4GB). This represents 1.39 percent ownership of the company. In their previous filing dated 2023-01-10 , State Street Corp had reported owning 27,843,985 shares, indicating a decrease of -95.26 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2023-05-10 2023-05-10 13G/A 27,843,985 1,319,485 -95.26 1.39 -95.28
2023-01-10 2023-01-10 13G 27,843,985 29.47

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GOSSAMER BIO COM 38341P102 4,388,109 -4,922,860 -52.87 1,441 -95.01 0.0000
2026-02-13 2025-12-31 13F GOSSAMER BIO COM 38341P102 9,310,969 5,427,302 139.75 28,864 182.59 0.0010
2025-11-14 2025-09-30 13F GOSSAMER BIO COM 38341P102 3,883,667 1,402,261 56.51 10,214 234.67 0.0004
2025-08-14 2025-06-30 13F GOSSAMER BIO COM 38341P102 2,481,406 1,598,730 181.12 3,052 214.64 0.0001
2025-05-15 2025-03-31 13F GOSSAMER BIO COM 38341P102 882,676 114,200 14.86 971 39.57 0.0000
2025-02-14 2024-12-31 13F GOSSAMER BIO COM 38341P102 768,476 55,700 7.81 695 -1.14 0.0000
2024-11-14 2024-09-30 13F GOSSAMER BIO COM 38341P102 712,776 0 0.00 703 9.50 0.0000
2024-08-14 2024-06-30 13F GOSSAMER BIO COM 38341P102 712,776 23,525 3.41 642 -21.03 0.0000
2024-05-15 2024-03-31 13F GOSSAMER BIO COM 38341P102 689,251 -24,300 -3.41 813 24.88 0.0000
2024-02-14 2023-12-31 13F GOSSAMER BIO COM 38341P102 713,551 383,400 116.13 651 137.59 0.0000
2023-11-14 2023-09-30 13F GOSSAMER BIO COM 38341P102 330,151 -14,600 -4.23 275 -33.66 0.0000
2023-08-14 2023-06-30 13F GOSSAMER BIO COM 38341P102 344,751 -978,746 -73.95 414 -75.22 0.0000
2023-05-15 2023-03-31 13F GOSSAMER BIO COM 38341P102 1,323,497 -26,520,488 -95.25 1,668 -97.24 0.0001
2023-05-15 2022-12-31 13F/A-99 GOSSAMER BIO COM 38341P102 27,843,985 24,066,082 637.02 60,421 33.50 0.0036
2023-05-15 2022-12-31 13F GOSSAMER BIO COM 38341P102 27,843,985 24,066,082 60,421 0.0036
2022-11-15 2022-09-30 13F GOSSAMER BIO COM 38341P102 3,777,903 -97,291 -2.51 45,259 39.54 0.0029
2022-08-15 2022-06-30 13F GOSSAMER BIO COM 38341P102 3,875,194 567,264 17.15 32,435 12.96 0.0019
2022-05-16 2022-03-31 13F GOSSAMER BIO COM 38341P102 3,307,930 15,839 0.48 28,713 -22.88 0.0014
2022-02-14 2021-12-31 13F GOSSAMER BIO COM 38341P102 3,292,091 629,325 23.63 37,234 11.24 0.0018
2021-11-15 2021-09-30 13F GOSSAMER BIO COM 38341P102 2,662,766 -664,950 -19.98 33,471 23.87 0.0018
2021-08-16 2021-06-30 13F GOSSAMER BIO COM 38341P102 3,327,716 -537,965 -13.92 27,021 -24.43 0.0014
2021-07-09 2021-03-31 13F/A-1 GOSSAMER BIO COM 38341P102 3,865,681 1,134,827 41.56 35,758 35.41 0.0021
2021-05-17 2021-03-31 13F GOSSAMER BIO COM 38341P102 3,865,681 1,134,827 35,758 0.0021
2021-02-16 2020-12-31 13F GOSSAMER BIO COM 38341P102 2,730,854 575,865 26.72 26,407 -1.26 0.0016
2020-11-10 2020-09-30 13F GOSSAMER BIO COM 38341P102 2,154,989 254,417 13.39 26,743 8.24 0.0018
2020-08-14 2020-06-30 13F GOSSAMER BIO COM 38341P102 1,900,572 241,674 14.57 24,707 46.73 0.0018
2020-06-19 2020-03-31 13F/A-1 GOSSAMER BIO COM 38341P102 1,658,898 13,649 0.83 16,838 -34.52 0.0015
2020-05-11 2020-03-31 13F GOSSAMER BIO COM 38341P102 1,658,898 13,649 16,838 1,478.7154
2020-02-06 2019-12-31 13F GOSSAMER BIO COM 38341P102 1,645,249 897,311 119.97 25,715 104.77 0.0018
2019-11-14 2019-09-30 13F GOSSAMER BIO COM 38341P102 747,938 400,491 115.27 12,558 62.96 0.0009
2019-08-14 2019-06-30 13F GOSSAMER BIO COM 38341P102 347,447 194,766 127.56 7,706 132.88 0.0006
2019-05-15 2019-03-31 13F GOSSAMER BIO COM 38341P102 152,681 152,681 3,309 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.